SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-165100
Filing Date
2017-05-10
Accepted
2017-05-10 08:16:49
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d368962d10q.htm 10-Q 482153
2 EX-31.1 d368962dex311.htm EX-31.1 9747
3 EX-31.2 d368962dex312.htm EX-31.2 9963
4 EX-32.1 d368962dex321.htm EX-32.1 5818
  Complete submission text file 0001193125-17-165100.txt   3675218

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20170331.xml EX-101.INS 931791
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20170331.xsd EX-101.SCH 31828
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20170331_cal.xml EX-101.CAL 26486
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20170331_def.xml EX-101.DEF 233019
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20170331_lab.xml EX-101.LAB 216881
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20170331_pre.xml EX-101.PRE 246400
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 17828570
SIC: 2834 Pharmaceutical Preparations